Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Innocenti

Showing results (71-80 of 186) with videos related to

Pageof 19
Sort By:
Clinical Pharmacology and Therapeutics|February 12, 2024
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the ModelSpinel Karas, Ron H J Mathijssen, Ron H N van Schaik, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2011
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patientsJacqueline Ramírez, Kehua Wu, Linda Janisch, et al.
Clinical Pharmacology and Therapeutics|May 9, 2022
Polygenic Risk Scores for Blood Pressure to Assess the Risk of Severe Bevacizumab-Induced Hypertension in Cancer Patients (Alliance)Julia C F Quintanilha, Amy S Etheridge, Brady J Graynor, et al.
Pharmacogenomics|March 3, 2012
Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicineKonstantinos Mitropoulos, Federico Innocenti, Ron H van Schaik, et al.
American Journal of Pharmaceutical Education|September 6, 2018
Challenges and Solutions for Future Pharmacy Practice in the Era of Precision MedicineOlivia M Dong, Rachel M Howard, Rachel Church, et al.
Human Mutation|February 15, 2014
Genomics into Healthcare: the 5th Pan Arab Human Genetics Conference and 2013 Golden Helix SymposiumPaolo Fortina, Najib Al Khaja, Mahmoud Taleb Al Ali, et al.
The Pharmacogenomics Journal|January 29, 2023
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patientsNancy Gillis, Amy S Etheridge, Sushant A Patil, et al.
American Journal of Human Genetics|June 4, 2019
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced ToxicityVasileios Fragoulakis, Rossana Roncato, Chiara Dalle Fratte, et al.
Angiogenesis|May 24, 2021
Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance)Julia C F Quintanilha, Yingmiao Liu, Amy S Etheridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2023
DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of MutationsFederico Innocenti, Wancen Mu, Xueping Qu, et al.
Pageof 19

Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|February 12, 2024
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the ModelSpinel Karas, Ron H J Mathijssen, Ron H N van Schaik, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2011
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patientsJacqueline Ramírez, Kehua Wu, Linda Janisch, et al.
Clinical Pharmacology and Therapeutics|May 9, 2022
Polygenic Risk Scores for Blood Pressure to Assess the Risk of Severe Bevacizumab-Induced Hypertension in Cancer Patients (Alliance)Julia C F Quintanilha, Amy S Etheridge, Brady J Graynor, et al.
Pharmacogenomics|March 3, 2012
Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicineKonstantinos Mitropoulos, Federico Innocenti, Ron H van Schaik, et al.
American Journal of Pharmaceutical Education|September 6, 2018
Challenges and Solutions for Future Pharmacy Practice in the Era of Precision MedicineOlivia M Dong, Rachel M Howard, Rachel Church, et al.
Human Mutation|February 15, 2014
Genomics into Healthcare: the 5th Pan Arab Human Genetics Conference and 2013 Golden Helix SymposiumPaolo Fortina, Najib Al Khaja, Mahmoud Taleb Al Ali, et al.
The Pharmacogenomics Journal|January 29, 2023
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patientsNancy Gillis, Amy S Etheridge, Sushant A Patil, et al.
American Journal of Human Genetics|June 4, 2019
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced ToxicityVasileios Fragoulakis, Rossana Roncato, Chiara Dalle Fratte, et al.
Angiogenesis|May 24, 2021
Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance)Julia C F Quintanilha, Yingmiao Liu, Amy S Etheridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2023
DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of MutationsFederico Innocenti, Wancen Mu, Xueping Qu, et al.
Pageof 19